HIC
TMO icon

Holderness Investments Company’s Thermo Fisher Scientific TMO Stock Holding History

Holderness Investments Company’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$442K Sell
900
-13
-1% -$7.05K 0.09% 171
2025
Q4 		$529K Hold
913
– – 0.11% 151
2025
Q3 		$443K Sell
913
-37
-4% -$17.2K 0.09% 169
2025
Q2 		$385K Sell
950
-344
-27% -$144K 0.08% 184
2025
Q1 		$644K Buy
1,294
+17
+1% +$9.21K 0.15% 134
2024
Q4 		$664K Buy
1,277
+21
+2% +$11.5K 0.15% 132
2024
Q3 		$777K Buy
1,256
+137
+12% +$81.1K 0.17% 121
2024
Q2 		$619K Buy
1,119
+16
+1% +$9.17K 0.15% 131
2024
Q1 		$641K Sell
1,103
-165
-13% -$92.6K 0.16% 134
2023
Q4 		$673K Sell
1,268
-247
-16% -$120K 0.18% 123
2023
Q3 		$767K Hold
1,515
– – 0.3% 88
2023
Q2 		$790K Sell
1,515
-45
-3% -$24.3K 0.29% 84
2023
Q1 		$899K Buy
1,560
+60
+4% +$33.8K 0.36% 71
2022
Q4 		$826K Buy
1,500
+107
+8% +$56.7K 0.36% 73
2022
Q3 		$707K Sell
1,393
-140
-9% -$78.3K 0.32% 82
2022
Q2 		$833K Hold
1,533
– – 0.35% 74
2022
Q1 		$905K Sell
1,533
-50
-3% -$28.7K 0.3% 82
2021
Q4 		$1.06M Hold
1,583
– – 0.31% 85
2021
Q3 		$904K Buy
1,583
+70
+5% +$38.4K 0.3% 89
2021
Q2 		$763K Buy
1,513
+95
+7% +$44.8K 0.25% 104
2021
Q1 		$647K Buy
1,418
+35
+3% +$16.7K 0.23% 105
2020
Q4 		$644K Buy
1,383
+253
+22% +$119K 0.25% 101
2020
Q3 		$499K Buy
1,130
+50
+5% +$20.7K 0.21% 108
2020
Q2 		$391K Buy
1,080
+35
+3% +$11.7K 0.17% 120
2020
Q1 		$296K Buy
1,045
+20
+2% +$6.31K 0.17% 124
2019
Q4 		$333K Hold
1,025
– – 0.14% 141
2019
Q3 		$299K Sell
1,025
-100
-9% -$28.6K 0.14% 146
2019
Q2 		$330K Buy
1,125
+325
+41% +$89.5K 0.15% 144
2019
Q1 		$219K Buy
+800
New +$199K 0.1% 174

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holderness Investments Company's TMO Position: Q1 2026 in Review

Holderness Investments Company reduced its Thermo Fisher Scientific (TMO) stake by 1.4% in Q1 2026, selling an estimated $7.05K and leaving 900 shares worth $442K. The position accounts for 0.09% of the portfolio, ranked #171.

Holderness Investments Company first reported a position in TMO in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.06M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Holderness Investments Company held 900 shares of Thermo Fisher Scientific worth $442K as of Q1 2026.
  • Holderness Investments Company sold 13 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.05K.
  • Thermo Fisher Scientific made up 0.09% of Holderness Investments Company's portfolio in Q1 2026, its #171 holding.
  • Holderness Investments Company first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 29 quarters since.
  • Holderness Investments Company's Thermo Fisher Scientific position peaked at $1.06M in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.